Welcome to the Week in Review.

1. “First, Cut The Costs Of Prescription Drugs”

2. Voters Are Watching

3. Seize This Moment

One more thing: The non-profit drug company Civica announced a plan to manufacture and sell biosimilars of some of the most widely used insulin products at a fraction of the brand-name prices. This could be a game changer for patients who depend on insulin to live, especially for those who are uninsured.